Author(s): de Jager ME, de Jong EM, van de Kerkhof PC, Seyger MM
Abstract Share this page
Abstract BACKGROUND: Evidence-based recommendations for therapeutic decision making in childhood psoriasis are lacking. OBJECTIVES: We sought to systematically review all available literature concerning treatment efficacy and safety in childhood psoriasis and to propose a recommendation for topical and systemic treatment of childhood psoriasis. METHODS: Databases searched were PubMed, EMBASE, and the Cochrane Controlled Clinical Trial Register. All studies reporting on efficacy and safety of all treatment options in childhood psoriasis were obtained and a level of evidence was determined. RESULTS: Literature search revealed 2649 studies, of which 64 studies met the inclusion criteria. The majority of topical and systemic therapies given in childhood psoriasis are efficacious. Short-term side effects were usually mild; long-term side effects were not described. LIMITATIONS: Most conclusions formulated are not based on randomized controlled trials. CONCLUSIONS: A rough summary of the proposed algorithm is as follows: first, calcipotriene with/without topical corticosteroids, followed by dithranol. Methotrexate is considered to be the systemic treatment of choice. Copyright 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
This article was published in J Am Acad Dermatol
and referenced in Journal of Clinical & Experimental Dermatology Research